Neurology News

Antibodies produced in response to COVID-19 may mistakenly target cells essential to the blood-brain barrier, which can cause bleeds and clots in patients and increase the risk for stroke, researchers reported in Brain.

The Parkinson’s Foundation has announced the expansion of its global care network with the addition of four Centers of Excellence and six Comprehensive Care Centers to increase access to high-quality care throughout the United States.

Gene therapy company uniQure has announced safety and biomarker data from 10 patients enrolled in the low-dose cohort of the ongoing phase 1/2 clinical trial of AMT-130 for treatment of Huntington’s disease.

Headache-related disability and PTSD symptom severity improved with cognitive behavioral therapy compared with usual care in United States military veterans with posttraumatic headache and PTSD, according to a study in JAMA Neurology.

Now that the Federal Reserve has raised interest rates for the first time since 2018, many in the financial media are revisiting the subject of inverted yield curves.

PTSD was associated with accelerated decline in cognitive function in middle-aged women, researchers reported in JAMA Network Open.

Continuous subcutaneous infusion of foslevodopa/foscarbidopa was safe and improved motor complications in patients with advanced Parkinson’s disease, according to data presented at the European Academy of Neurology Congress 2022.

A thin optical fiber shows promise for use in minimally invasive deep tissue studies in brains affected by Alzheimer’s disease, researchers reported in APL Photonics.

Racial inequities in health care have fluctuated in severity for decades but data show that one constant remains: the disparities persist.

Neurona Therapeutics has announced that a phase 1/2 clinical trial for NRTX-1001, a regenerative neural cell therapy for treatment of drug-resistant focal epilepsy in adults, is now underway.